当前胚胎植入前遗传学检测定量方法常将减数分裂非整倍体误判为嵌合体
该回顾性队列研究对2018至2020年伦敦The Evewell的87例患者共146枚胚胎行基于NGS的PGT-A,并用单核苷酸多态性基因分型和核型定位追溯染色体错误起源。141枚报告为嵌合的胚胎中32.6%(46/141)含减数分裂起源错误,191个嵌合范围错误中29.3%(56/191)为减数分裂起源,94.6%的减数分裂错误为母源。
要点
- NGS-based PGT-A报告的嵌合胚胎中32.6%(46/141)实含减数分裂错误。
- 嵌合范围191个染色体错误中29.3%(56/191)为减数分裂起源,94.6%为母源。
- 多个染色体异常的胚胎更可能含至少一个减数分裂错误,中间拷贝数值越高概率越大。
核心结论
- 本研究首次提供直接证据:NGS-based PGT-A报告为嵌合(低水平和高水平嵌合)的胚胎中约三分之一含减数分裂错误,提示当前方法可能将非整倍体胚胎误分类为嵌合体。
- 单核苷酸多态性基因分型可为准确判定染色体异常起源提供关键信息,应与NGS拷贝数分析整合以提高诊断准确性。
- 需进一步研究以完善嵌合体分类并更好理解其在体外受精治疗中的真实意义。
研究设计与样本
- 回顾性队列研究,采用单核苷酸多态性基因分型和核型定位在临床报告为嵌合的胚胎中识别减数分裂非整倍体。
- 样本为2018至2020年在伦敦The Evewell接受体外受精周期并行NGS-based PGT-A的87例患者的146枚胚胎。
- 对同一扩增材料行单核苷酸多态性基因分型和核型定位以确定染色体错误起源。
主要发现
- 141枚NGS-based PGT-A报告为嵌合的胚胎中,32.6%(n=46/141)含减数分裂起源错误。
- NGS-based PGT-A在嵌合范围共报告191个染色体错误,其中29.3%(56/191)为减数分裂起源,包括低于和高于50%拷贝数阈值者。
- 减数分裂错误中94.6%为母源。
- 含多个染色体异常的胚胎显著更可能具有至少一个减数分裂错误。
- 较高的中间拷贝数值与错误为减数分裂起源的概率增加相关。
临床怎么用
- 作者认为单核苷酸多态性基因分型应与NGS拷贝数分析整合,以提高染色体异常起源判定的诊断准确性。
- 作者建议需进一步研究以完善嵌合体分类并更好理解其在体外受精治疗中的真实意义。
局限性
- 需进一步研究以完善嵌合体分类并更好理解其在体外受精治疗中的真实意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study the biological origin of chromosomal abnormalities in embryos reported as mosaic after next-generation sequencing (NGS)-based preimplantation genetic testing for aneuploidy (PGT-A) and to assess the accuracy of current NGS-based methods in distinguishing meiotic from mitotic errors. DESIGN: Retrospective cohort study utilizing single-nucleotide polymorphism genotyping and karyomapping to identify meiotic aneuploidy in clinically reported mosaic embryos. SUBJECTS: A total of 146 embryos from 87 patients who underwent in vitro fertilization cycles with NGS-based PGT-A between 2018 and 2020 at The Evewell, London, United Kingdom. EXPOSURE: Embryos underwent clinical NGS-based PGT-A to identify chromosomal abnormalities. Haplotype-based methods such as single-nucleotide polymorphism-based genotyping and karyomapping were performed on the same amplified material used for NGS-based PGT-A to determine the origin of the chromosomal errors. MAIN OUTCOME MEASURES: The proportion of embryos reported as mosaic by NGS that contained meiotic errors, and the distribution of meiotic vs. mitotic origin among chromosomal abnormalities identified in the mosaic range. RESULTS: Of the 141 embryos identified as mosaic after NGS-based PGT-A, 32.6% (n = 46/141) contained an error of meiotic origin, challenging their classification as "mosaic embryos." In total, 191 individual chromosomal errors were reported in the mosaic range by NGS-based PGT-A. Of those, 29.3% (56/191) errors (both below and above the 50% copy number threshold) were found to be of meiotic origin. The majority (94.6%) of meiotic errors were maternal in origin. Embryos with multiple chromosomal abnormalities were significantly more likely to have at least one meiotic error. Higher intermediate copy number values correlated with an increased probability of an error being of meiotic origin. CONCLUSION: This study presents the first direct evidence that a third of embryos reported as mosaic (both low- and high-level mosaic) by NGS-based PGT-A contain meiotic errors, highlighting the potential misclassification of aneuploid embryos as mosaic by current NGS-based PGT-A methods that cannot accurately distinguishing between meiotic and mitotic errors. Single-nucleotide polymorphism genotyping provides essential information for accurately determining the origin of chromosomal abnormalities and should be integrated with NGS-based copy number analysis to enhance diagnostic accuracy. Further studies are needed to refine mosaicism classification and to better understand its true implications in in vitro fertilization treatment.
引用
- Popa T, Davis C, Xanthopoulou L, et al. Current quantitative methodologies for preimplantation genetic testing frequently misclassify meiotic aneuploidies as mosaic. Fertil Steril. 2025. PMID: 39961387. doi:10.1016/j.fertnstert.2025.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。